DEPENDENCE OF YKL-40 mRNA TISSUE LEVELS ON KRAS MUTATION STATUS IN COLORECTAL CANCER - PRELIMINARY RESULTS
Colorectal cancer (CRC) is one of the most deadly cancers worldwide. Despite the introduction of targeted molecular therapies in the last 10 years, overall survival has not increased substantially. CRC progression is accompanied by numerous genetic and epigenetic alterations and dysregulation of sev...
Main Authors: | Yana Feodorova, Dessislava Tashkova, Kiril Simitchiev, Anton Todorov, Gancho Kostov, Rossen Dimov, Victoria Sarafian |
---|---|
Format: | Article |
Language: | English |
Published: |
Bulgarian Association of Young Surgeons
2015-08-01
|
Series: | International Journal of Surgery and Medicine |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=195942 |
Similar Items
-
Prognostic Impact of YKL-40 Immunohistochemical Expression in Patients with Colorectal Cancer
by: Il Hwan Oh, et al.
Published: (2021-08-01) -
SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014-06-01) -
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
by: Abolfazl Yari, et al.
Published: (2020-06-01) -
The role of YKL-40 in a cancerous process
by: Agnieszka Rusak, et al.
Published: (2016-12-01) -
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
by: Pang X, et al.
Published: (2017-05-01)